Advarra aims to accelerate pediatric trials in an agreement

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/shironosov)
(Image: Getty/shironosov)

Related tags: advarra, Pediatrics, Clinical trial, Clinical research, Clinical trial sites, Clinical trial site, Irb

Advarra will provide IRB services to the Institute for Advanced Clinical Trials for Children’s pediatric clinical trial site network.

The institutional review board (IRB) service provider will work with the Institute for Advanced Clinical Trials (I-ACT) for Children as it grows its trial site network, which currently includes 44 pediatric research sites in the US.

I-ACT for Children aims to accelerate biomedical innovation for child-centered clinical trial networks and stakeholders to accelerate site startup and completion of global pediatric studies. Pat Donnelly, CEO of Advarra told us that the network is focusing specifically on pediatrics to accelerate the establishment of safety and effectiveness data for approved and unapproved treatments.

Which Laura Gordon, CEO of I-ACT for Children, said in a statement that providing central IRB services as part of the site network is an imperative aspect of making pediatric trials more efficient.

He added that the network is continuing to add patients, investigators, and caregivers to provide independent guidance on developing the most respectful pediatric plans and protocols possible.

The US Food and Drug Administration (FDA) requires specific additional protections to be considered in pediatric trials, “this includes determining the specific level of risk presented, the prospect of direct benefit, and determining whether assent is necessary, and if so, how it’s documented,”​ said Donnelly.

Related news

Show more

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us

Products

View more

Webinars